Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 11, 2014, Pages 1145-1148

  Kandiah, Nagaendran ^a,b   Zhang, Angeline ^a   Cenina, Alvin Rae ^a   Au, Wing Lok ^a,b   Nadkarni, Nivedita ^c   Tan, Louis Cs ^a,b  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cognitive functions; Dementia; Parkinson's disease

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOEHN AND YAHR SCALE; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MOVEMENT DISORDER TASKFORCE CRITERION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PARKINSON DISEASE; PATIENT CODING; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; COGNITION DISORDERS; COMPLICATION; MASS SCREENING; NEUROPSYCHOLOGICAL TEST;

AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84908593319     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.08.002     Document Type: Article

References (31)

1. Marras C., McDermott M.P., Rochon P.A., Tanner C.M., Naglie G., Lang A.E., et al. Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord 2008, 23(5):653-659.
2. Klepac N., Trkulja V., Relja M., Babic T. Is quality of life in non-demented Parkinson's disease patients related to cognitive performance? A clinic-based cross-sectional study. Eur J Neurol 2008, 15:128-133.
3. Kandiah N., Mak E., Ng A., et al. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat Disord 2013, 19(7):680-683.
4. Litvan I., Aarsland D., Adler C.H., et al. MDS task force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011, 26(10):1814-1824.
5. Muslimovic D., Post B., Speelman J.D., Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005, 65(8):1239-1245.
6. Verbaan D., Marinus D., Visser M., et al. Cognitive impairment in Parkinson's disease. JNeurol Neurosurg Psychiatry 2007, 2007(78):1182-1187.
7. Mamikonyan E., Moberg P.J., Siderowf A., et al. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2009 March, 15(3):226-231.
8. Shin J., Choi S., Lee J.E., Lee H.S., Sohn Y.H., Lee P.H. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status. JNeurol Neurosurg Psychiatry 2012, 83:315-321.
9. Pfeiffer H.C.V., Løkkegaard A., Zoetmulder M., Friberg L., Werdelin L. Cognitive impairment in early-stage non-demented Parkinson's disease patients. Acta Neurol Scand 2014, 129:307-318.
10. Bronnick K., Emre M., Lane R., et al. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. JNeurol Neurosurg Psychiatry 2007, 78:1064-1068.
11. Yu R.L., Wu R.M., Tai C.H., Lin C.H., Cheng T.W., Hua M.S. Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan. Parkinsonism Relat Disord 2012, 18(10):1067-1072.
12. Mak E., Zhou J., Tan L.C., Au W.L., Sitoh Y.Y., Kandiah N. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy. JNeurol Neurosurg Psychiatry 2013, 0:1-5.
13. Lee J.E., Cho K.H., Song S.K., et al. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease. JNeurol Neurosurg Psychiatry 2014, 85:7-16.
14. Biundo R., Weis L., Facchini S., et al. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism Relat Disord 2014, 20(4):394-399.
15. Litvan I., Goldman J.G., Troster A.l., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov Disord 2012, 27(3):349-356.
16. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment (MoCA): a brief screening tool for mild cognitive impairment. JAGS 2005, 53(4):695-699.
17. Hoops S., Nazem S., Siderowf A.D., et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 2009, 73:1738-1745.
18. Dalrymple-Alford J.C., MacAskill M.R., Nakas C.T., et al. The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010, 75(19):1717-1725.
19. Gill D.J., Freshman A., Blender J.A., Ravina B. The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov Disord 2008, 23(7):1043-1046.
20. Zadikoff C., Fox S.H., Tang-Wai D.F., et al. Acomparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord 2008, 23(2):297-299.
21. Chou K.L., Amick M.M., Brandt J., et al. Arecommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord 2010, 25(15):2501-2507.
22. Hu M.T.M., Szewczyk-Krolikowski K., Tomlinson P., et al. Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Mov Disord 2014, 29(3):351-359.
23. Lessig S., Nie D., Xu R., Corey-Bloom J. Changes on brief cognitive instruments over time in Parkinson's disease. Mov Disord 2012, 27(9):1125-1128.
24. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for parkinson disease. JAMA Neurol 1999, 56(1):33-39.
25. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinicians. JPsychiatr Res 1975, 12:189-198.
26. Rosen W., Mohs R.C., Davis K.L. Anew rating scale for Alzheimer's disease. Am J Psychiatry 1984, 141(11):1356-1364.
27. Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000, 55(11):1621-1626.
28. Sunderland T., Hill J.L., Mellow A.M., Lawlor B.A., Gundersheimer J., Newhouse P.A., et al. Clock drawing in Alzheimer's disease: a novel measure of dementia severity. JAGS 1989, 37(8):725-729.
29. Lee C.K., Collinson S.L., Feng L., Ng T.P. Preliminary normative neuropsychological data for an elderly chinese population. Clin Neuropsychol 2012, 26(2):321-334.
30. Ng A., Chew I., Narasimhalu K., Kandiah N. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore. Singapore Med J 2013 Nov, 54(11):616-619.
31. Dubois B., Burn D., Goetz C., Aarsland D., Brown R.G., Broe G.A. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord 2007, 22(16):2314-2324.